이종찬A
#췌장암#담도암#담낭암#췌장염#기타 담낭/담도 질환#담석질환치료
|
학력
서울대학교 의과대학 의학사
서울대학교 보건대학원 보건정책 석사
서울대학교 의과대학 의학박사
서울대학교 보건대학원 보건정책 석사
서울대학교 의과대학 의학박사
경력
서울대학교병원 수련의
인천사랑병원 전공의
분당서울대학교병원 전임의
분당서울대학교병원 진료전문의
분당서울대학교병원 소화기내과 조교수
현재 분당서울대학교병원 소화기내과 부교수
인천사랑병원 전공의
분당서울대학교병원 전임의
분당서울대학교병원 진료전문의
분당서울대학교병원 소화기내과 조교수
현재 분당서울대학교병원 소화기내과 부교수
논문
Lee JC*, Shin DW, Park H, Kim J, Youn Y, Kim JH, Kim J, Hwang JH. Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: Phase I Trial. Gastrointest Endosc. 2020 Feb 18. pii: S0016-5107(20)30138-3.
Park JM, Kang CD, Lee JC*, Hwang JH, Kim J. Recent 5-Year Trend of Endoscopic Retrograde Cholangiography in Korea Using National Health Insurance Review and Assessment Service Open Data. Gut Liver. 2019 Dec 13. doi: 10.5009/gnl19249.
Lee YS, Lee JC*, Yang SY, Kim J, Hwang JH. Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis. Sci Rep. 2019 Oct 30;9(1):15662. (Co-first)
Cho IK, Kim H, Lee JC*, Lee J, Kim J, Ahn S, Park H, Hwang JH. Higher Tumor Cellularity in Resected Pancreatic Ductal Adenocarcinoma Is a Negative Prognostic Indicator. Gut Liver. 2019 Oct 18.
Hwang YJ, Park SM, Ahn S, Lee JC*, Park YS, Kim N. Accuracy of an administrative database for pancreatic cancer by international classification of disease 10th codes: A retrospective large-cohort study. World J Gastroenterol. 2019 Oct 7;25(37):5619-5629.
Jang ES, Park SM, Park YS, Lee JC*, Kim N. Work-Life Conflict and Its Health Effects on Korean Gastroenterologists According to Age and Sex. Dig Dis Sci. 2019 Sep 23. doi: 10.1007/s10620-019-05842-w.
Ahn S, Lee JC*, Hwang JH, Yoon YS, Lee KH, Zen Y. Duct-obstructive pancreatitis with granulocytic epithelial lesion in a patient with ulcerative colitis: An atypical manifestation of type 2 autoimmune pancreatitis? Pathol Int. 2019 Jul;69(7):420-426.
Shin DW, Lee JC*, Kim J, Woo SM, Lee WJ, Han SS, Park SJ, Choi KS, Cha HS, Yoon YS, Han HS, Hong EK, Hwang JH. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2019 Nov;45(11):2159-2165.
Ahn S, Lee Y, Kim JW, Lee JC*, Hwang JH, Yoon YS, Cho JY, Han HS, Choi Y, Kim H. Programmed cell death ligand-1 (PD-L1) ex-pression in extrahepatic biliary tract cancers: a comparative study using 22C3, SP263 and E1L3N anti-PD-L1 antibodies. Histopathology. 2019 Oct;75(4):526-536.
Lee J, Lee JC*, Gromski MA, Kim HW, KimJ, Kim J, Hwang JH. Clinical outcomes of FOLFIRINOX in locally advancedpancreatic cancer: A single center experience. Medicine(Baltimore). 2018Dec;97(50):e13592.
Kim J, Kim H, Lee JC*, Kim JW, Paik WH,Lee SH, Hwang JH,Ryu JK, Kim YT. Human equilibrative nucleoside transporter 1(hENT1) ex-pression as a predictive biomarker for gemcitabine chemotherapy inbiliary tract cancer. PLoS One. 2018 Dec 17;13(12):e020910
Lee JC*, Kim JS, Kim HW, Cho IK, Lee J, Jang ES, Lee SH, Hwang JH, Kim JW, Jeong SH, KimJ. Outcome of endoscopic retrograde cholangiopancreatographyin patients withclinically defined decompensated liver cirrhosis. J Dig Dis. 2018Oct;19(10):605-613.
Lee JC*, Kim H, Kim HW, Lee J, Paik KH, Kang J, Hwang JH, Kim J. It is necessary to exambottom and top slide smears of EUS-FNA for pancreaticcancer. HepatobiliaryPancreat Dis Int. 2018 Dec;17(6):553-558.
Lee B, Yoo S, Kim Y, Song H, Lee JC*, Hwang JH, Kim B, Seo J. Interactive Visualization Tool for Effective Evidence Mapping with Medical Research Papers. KIISE Transactions on Computing Practices. 2018 Dec; 24. 662-669. 10.5626/KTCP.2018.24.12.662.
KimHW, Lee JC*, Paik KH, Kang J, Kim YH,Yoon YS, HanHS, Kim J, Hwang JH. Adjunctive role of preoperative livermagnetic resonance imaging for potentially resectable pancreatic cancer.Surgery. 2017 Jun;161(6):1579-1587.
LeeJC*, Ahn S, Cho IK, Lee J, Kim J, Hwang JH. Management of recurrent pancreaticcancer after surgical resection: a protocol for systematicreview, evidencemapping and meta-analysis. BMJ Open. 2018 Apr 9;8(4):e017249.
LeeJC*, Kim JW, Ahn S, Kim HW, Lee J, Kim YH, Paik KH, Kim J, Hwang JH. Optimal dosereduction of FOLFIRINOX for preserving tumour responsein advanced pancreaticcancer: Using cumulative relative dose intensity. Eur J Cancer. 2017May;76:125-133.
ShimYK, Kim N, Park YH, Lee JC*, Sung J,Choi YJ, YoonH, Shin CM, Park YS, Lee DH. Effects of Age on EsophagealMotility: Use of High-resolution Esophageal Impedance Manometry. JNeurogastroenterol Motil. 2017 Apr 30;23(2):229-236.
YoonK, Kim N, Kim J, Lee JW, Lee HS, Lee JC*, Yoon H, Shin CM, Park YS, Ahn SH, ParkDJ, Kim HH, Lee YJ, Lee KH, Kim YH, LeeDH. Dynamic Changes in Helicobacter pylori Status Following Gastric CancerSurgery. Gut Liver. 2017 Mar 15;11(2):209-215.
KimHW, Lee JC*, Paik KH, Kang J, Kim J,Hwang JH. Seruminterleukin-6 is associated with pancreatic ductaladenocarcinoma progression pattern. Medicine (Baltimore). 2017 Feb;96(5):e5926.
ChoiJH, Kim HW, Lee JC*, Paik KH, Seong NJ, Yoon CJ, Hwang JH, Kim J. Percutaneous transhepatic versus EUS-guidedgallbladder drainage for malignant cystic duct obstruction. GastrointestEndosc. 2017 Feb;85(2):357-364.
KimHW, Lee JC*, Lee J, Kim JW, Kim J,Hwang JH. Earlyversus delayed initiation of adjuvant treatment for pancreaticcancer. PLoS One. 2017 Mar 16;12(3):e0173960.
ChoiYJ, Kim N, Lee JY, Nam RH, Suh JH,Lee SM, Ham MH, Jo HJ, Shim YK, Park YH, Lee JC*, Choi YJ, Lee HS, Lee DH. PMK-S005Alleviates Age-Related Gastric Acid Secretion, Inflammation, and OxidativeStatus in the Rat Stomach. Gut Liver. 2016 Sep 15;10(5):749-56.
PaikKH, Lee JC*, Kim HW, Kang J, Lee YS,Hwang JH, AhnSH, Park DJ, Kim HH, Kim J. Risk Factors for Gallstone Formationin Resected Gastric Cancer Patients. Medicine (Baltimore). 2016Apr;95(15):e3157.
Lee JC*, Ro YS, Cho J, Park Y, Lee JH, Hwang JH, Choi HJ, Lee S. Characteristics ofVenous Thromboembolism in Pancreatic Adenocarcinoma in EastAsian Ethnics: ALarge Population-Based Observational Study. Medicine (Baltimore). 2016Apr;95(17):e3472.
LeeJC*, Ahn S, Paik KH, Kim HW, Kang J, Kim J, Hwang JH. Clinical impact of neoadjuvanttreatment in resectable pancreatic cancer: a systematicreview and meta-analysisprotocol. BMJ Open. 2016 Mar 25;6(3):e010491.
Kang J, Paik KH, Lee JC*, Kim HW, Lee J,Hwang JH,Kim J. The Efficacy of Clinical Predictors for Patients withIntermediate Risk of Choledocholithiasis. Digestion. 2016;94(2):100-105.
Lee YS, Kim H, Kim HW, Lee JC*, Paik KH, Kang J, Kim J, Yoon YS, HanHS, Sohn I, Cho J, Hwang JH. High ex-pression ofMicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic NeuroendocrineTumor. Medicine (Baltimore). 2015 Dec;94(50):e2224.
LeeYS, Paik KH, Kim HW, Lee JC*, Kim J,Hwang JH. Comparison of EndoscopicUltrasonography, Computed Tomography, andMagnetic Resonance Imaging for Pancreas Cystic Lesions. Medicine (Baltimore).2015 Oct;94(41):e1666.
KimHW, Lee JC*, Paik KH, Lee YS, HwangJH, Kim J. InitialMetastatic Site as a Prognostic Factor in Patients WithStage IV Pancreatic Ductal Adenocarcinoma. Medicine (Baltimore). 2015Jun;94(25):e1012.
Cho J, Park Y, Lee JC*, Jung WJ, Lee S.Case series of differentonset of skin metastasis according to the breastcancer subtypes. Cancer Res Treat. 2014 Apr;46(2):194-9.
Kim SH, Chung JH, Lee JC*, Park YH, Joe JH, Hwang HJ. Carboxy-terminalprovasopressin may predict prognosis in nursinghome acquired pneumonia. Clin Chim Acta. 2013 Jun 5;421:226-9.
Lee JC*, Hwang HJ, Park YH, Joe JH, Chung JH, Kim SH. Comparison of severity predictiverules for hospitalised nursing home-acquired pneumoniain Korea: aretrospective observational study. Prim Care Respir J. 2013 Jun;22(2):149-54.
Lim S,Han J, Park KH, Jung WJ, Lee YK, Choi A, Kim YJ, Lee JC*, Choi HJ. Two cases of humoral hypercalcemia of malignancyin metastatic cholangiocarcinoma. Cancer Res Treat. 2013 Jun;45(2):145-9.
Park JM, Kang CD, Lee JC*, Hwang JH, Kim J. Recent 5-Year Trend of Endoscopic Retrograde Cholangiography in Korea Using National Health Insurance Review and Assessment Service Open Data. Gut Liver. 2019 Dec 13. doi: 10.5009/gnl19249.
Lee YS, Lee JC*, Yang SY, Kim J, Hwang JH. Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis. Sci Rep. 2019 Oct 30;9(1):15662. (Co-first)
Cho IK, Kim H, Lee JC*, Lee J, Kim J, Ahn S, Park H, Hwang JH. Higher Tumor Cellularity in Resected Pancreatic Ductal Adenocarcinoma Is a Negative Prognostic Indicator. Gut Liver. 2019 Oct 18.
Hwang YJ, Park SM, Ahn S, Lee JC*, Park YS, Kim N. Accuracy of an administrative database for pancreatic cancer by international classification of disease 10th codes: A retrospective large-cohort study. World J Gastroenterol. 2019 Oct 7;25(37):5619-5629.
Jang ES, Park SM, Park YS, Lee JC*, Kim N. Work-Life Conflict and Its Health Effects on Korean Gastroenterologists According to Age and Sex. Dig Dis Sci. 2019 Sep 23. doi: 10.1007/s10620-019-05842-w.
Ahn S, Lee JC*, Hwang JH, Yoon YS, Lee KH, Zen Y. Duct-obstructive pancreatitis with granulocytic epithelial lesion in a patient with ulcerative colitis: An atypical manifestation of type 2 autoimmune pancreatitis? Pathol Int. 2019 Jul;69(7):420-426.
Shin DW, Lee JC*, Kim J, Woo SM, Lee WJ, Han SS, Park SJ, Choi KS, Cha HS, Yoon YS, Han HS, Hong EK, Hwang JH. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2019 Nov;45(11):2159-2165.
Ahn S, Lee Y, Kim JW, Lee JC*, Hwang JH, Yoon YS, Cho JY, Han HS, Choi Y, Kim H. Programmed cell death ligand-1 (PD-L1) ex-pression in extrahepatic biliary tract cancers: a comparative study using 22C3, SP263 and E1L3N anti-PD-L1 antibodies. Histopathology. 2019 Oct;75(4):526-536.
Lee J, Lee JC*, Gromski MA, Kim HW, KimJ, Kim J, Hwang JH. Clinical outcomes of FOLFIRINOX in locally advancedpancreatic cancer: A single center experience. Medicine(Baltimore). 2018Dec;97(50):e13592.
Kim J, Kim H, Lee JC*, Kim JW, Paik WH,Lee SH, Hwang JH,Ryu JK, Kim YT. Human equilibrative nucleoside transporter 1(hENT1) ex-pression as a predictive biomarker for gemcitabine chemotherapy inbiliary tract cancer. PLoS One. 2018 Dec 17;13(12):e020910
Lee JC*, Kim JS, Kim HW, Cho IK, Lee J, Jang ES, Lee SH, Hwang JH, Kim JW, Jeong SH, KimJ. Outcome of endoscopic retrograde cholangiopancreatographyin patients withclinically defined decompensated liver cirrhosis. J Dig Dis. 2018Oct;19(10):605-613.
Lee JC*, Kim H, Kim HW, Lee J, Paik KH, Kang J, Hwang JH, Kim J. It is necessary to exambottom and top slide smears of EUS-FNA for pancreaticcancer. HepatobiliaryPancreat Dis Int. 2018 Dec;17(6):553-558.
Lee B, Yoo S, Kim Y, Song H, Lee JC*, Hwang JH, Kim B, Seo J. Interactive Visualization Tool for Effective Evidence Mapping with Medical Research Papers. KIISE Transactions on Computing Practices. 2018 Dec; 24. 662-669. 10.5626/KTCP.2018.24.12.662.
KimHW, Lee JC*, Paik KH, Kang J, Kim YH,Yoon YS, HanHS, Kim J, Hwang JH. Adjunctive role of preoperative livermagnetic resonance imaging for potentially resectable pancreatic cancer.Surgery. 2017 Jun;161(6):1579-1587.
LeeJC*, Ahn S, Cho IK, Lee J, Kim J, Hwang JH. Management of recurrent pancreaticcancer after surgical resection: a protocol for systematicreview, evidencemapping and meta-analysis. BMJ Open. 2018 Apr 9;8(4):e017249.
LeeJC*, Kim JW, Ahn S, Kim HW, Lee J, Kim YH, Paik KH, Kim J, Hwang JH. Optimal dosereduction of FOLFIRINOX for preserving tumour responsein advanced pancreaticcancer: Using cumulative relative dose intensity. Eur J Cancer. 2017May;76:125-133.
ShimYK, Kim N, Park YH, Lee JC*, Sung J,Choi YJ, YoonH, Shin CM, Park YS, Lee DH. Effects of Age on EsophagealMotility: Use of High-resolution Esophageal Impedance Manometry. JNeurogastroenterol Motil. 2017 Apr 30;23(2):229-236.
YoonK, Kim N, Kim J, Lee JW, Lee HS, Lee JC*, Yoon H, Shin CM, Park YS, Ahn SH, ParkDJ, Kim HH, Lee YJ, Lee KH, Kim YH, LeeDH. Dynamic Changes in Helicobacter pylori Status Following Gastric CancerSurgery. Gut Liver. 2017 Mar 15;11(2):209-215.
KimHW, Lee JC*, Paik KH, Kang J, Kim J,Hwang JH. Seruminterleukin-6 is associated with pancreatic ductaladenocarcinoma progression pattern. Medicine (Baltimore). 2017 Feb;96(5):e5926.
ChoiJH, Kim HW, Lee JC*, Paik KH, Seong NJ, Yoon CJ, Hwang JH, Kim J. Percutaneous transhepatic versus EUS-guidedgallbladder drainage for malignant cystic duct obstruction. GastrointestEndosc. 2017 Feb;85(2):357-364.
KimHW, Lee JC*, Lee J, Kim JW, Kim J,Hwang JH. Earlyversus delayed initiation of adjuvant treatment for pancreaticcancer. PLoS One. 2017 Mar 16;12(3):e0173960.
ChoiYJ, Kim N, Lee JY, Nam RH, Suh JH,Lee SM, Ham MH, Jo HJ, Shim YK, Park YH, Lee JC*, Choi YJ, Lee HS, Lee DH. PMK-S005Alleviates Age-Related Gastric Acid Secretion, Inflammation, and OxidativeStatus in the Rat Stomach. Gut Liver. 2016 Sep 15;10(5):749-56.
PaikKH, Lee JC*, Kim HW, Kang J, Lee YS,Hwang JH, AhnSH, Park DJ, Kim HH, Kim J. Risk Factors for Gallstone Formationin Resected Gastric Cancer Patients. Medicine (Baltimore). 2016Apr;95(15):e3157.
Lee JC*, Ro YS, Cho J, Park Y, Lee JH, Hwang JH, Choi HJ, Lee S. Characteristics ofVenous Thromboembolism in Pancreatic Adenocarcinoma in EastAsian Ethnics: ALarge Population-Based Observational Study. Medicine (Baltimore). 2016Apr;95(17):e3472.
LeeJC*, Ahn S, Paik KH, Kim HW, Kang J, Kim J, Hwang JH. Clinical impact of neoadjuvanttreatment in resectable pancreatic cancer: a systematicreview and meta-analysisprotocol. BMJ Open. 2016 Mar 25;6(3):e010491.
Kang J, Paik KH, Lee JC*, Kim HW, Lee J,Hwang JH,Kim J. The Efficacy of Clinical Predictors for Patients withIntermediate Risk of Choledocholithiasis. Digestion. 2016;94(2):100-105.
Lee YS, Kim H, Kim HW, Lee JC*, Paik KH, Kang J, Kim J, Yoon YS, HanHS, Sohn I, Cho J, Hwang JH. High ex-pression ofMicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic NeuroendocrineTumor. Medicine (Baltimore). 2015 Dec;94(50):e2224.
LeeYS, Paik KH, Kim HW, Lee JC*, Kim J,Hwang JH. Comparison of EndoscopicUltrasonography, Computed Tomography, andMagnetic Resonance Imaging for Pancreas Cystic Lesions. Medicine (Baltimore).2015 Oct;94(41):e1666.
KimHW, Lee JC*, Paik KH, Lee YS, HwangJH, Kim J. InitialMetastatic Site as a Prognostic Factor in Patients WithStage IV Pancreatic Ductal Adenocarcinoma. Medicine (Baltimore). 2015Jun;94(25):e1012.
Cho J, Park Y, Lee JC*, Jung WJ, Lee S.Case series of differentonset of skin metastasis according to the breastcancer subtypes. Cancer Res Treat. 2014 Apr;46(2):194-9.
Kim SH, Chung JH, Lee JC*, Park YH, Joe JH, Hwang HJ. Carboxy-terminalprovasopressin may predict prognosis in nursinghome acquired pneumonia. Clin Chim Acta. 2013 Jun 5;421:226-9.
Lee JC*, Hwang HJ, Park YH, Joe JH, Chung JH, Kim SH. Comparison of severity predictiverules for hospitalised nursing home-acquired pneumoniain Korea: aretrospective observational study. Prim Care Respir J. 2013 Jun;22(2):149-54.
Lim S,Han J, Park KH, Jung WJ, Lee YK, Choi A, Kim YJ, Lee JC*, Choi HJ. Two cases of humoral hypercalcemia of malignancyin metastatic cholangiocarcinoma. Cancer Res Treat. 2013 Jun;45(2):145-9.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
(특허) 전동드릴 장착용 내시경 캡: (Patent No: 10-1640756)
(특허) 인체 내 결석추출 엄브렐라 바스켓 및 어셈블리 (Patent No: 10-1805296)
(특허) 단층촬영 이미지로부터 자동으로 근육량을 계산하는 방법 (Patent No:10-1936506)
(IT) 복합항암제 누적용량 계산 알고리즘: www.rdicalc.com
(IT) Evidence Mapping Program: www.plotting-e-map.com
(Mobile App) 병원용 한국어-러시아어 간편 통역기, 스눕 지아이
(특허) 인체 내 결석추출 엄브렐라 바스켓 및 어셈블리 (Patent No: 10-1805296)
(특허) 단층촬영 이미지로부터 자동으로 근육량을 계산하는 방법 (Patent No:10-1936506)
(IT) 복합항암제 누적용량 계산 알고리즘: www.rdicalc.com
(IT) Evidence Mapping Program: www.plotting-e-map.com
(Mobile App) 병원용 한국어-러시아어 간편 통역기, 스눕 지아이